Compile Data Set for Download or QSAR
Report error Found 109 Enz. Inhib. hit(s) with all data for entry = 11397
TargetSynaptic vesicular amine transporter(Human)
Neurocrine Biosciences

US Patent
LigandPNGBDBM611952(US11718618, Compound 4-119 | (2R,3R,11bR)-9- (cycl...)
Affinity DataKi:  0.290nMAssay Description:The human VMAT2 Ki values for the compounds listed in Table 15A and Table 15B were determined using the following procedures. Compound dilution serie...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/17/2023
Entry Details
US Patent

TargetSynaptic vesicular amine transporter(Human)
Neurocrine Biosciences

US Patent
LigandPNGBDBM611939(US11718618, Compound 4-90 | (2R,3R,11bR)-3-(2,2- d...)
Affinity DataKi:  0.290nMAssay Description:The human VMAT2 Ki values for the compounds listed in Table 15A and Table 15B were determined using the following procedures. Compound dilution serie...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/17/2023
Entry Details
US Patent

TargetSynaptic vesicular amine transporter(Human)
Neurocrine Biosciences

US Patent
LigandPNGBDBM611867(US11718618, Compound 4-23 | 1-(2-{[(2R,3R,11bR)-3-...)
Affinity DataKi:  0.410nMAssay Description:The human VMAT2 Ki values for the compounds listed in Table 15A and Table 15B were determined using the following procedures. Compound dilution serie...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/17/2023
Entry Details
US Patent

TargetSynaptic vesicular amine transporter(Human)
Neurocrine Biosciences

US Patent
LigandPNGBDBM611873(US11718618, Compound 4-28 | (2R,3R,11bR)-3-(2,2- d...)
Affinity DataKi:  0.480nMAssay Description:The human VMAT2 Ki values for the compounds listed in Table 15A and Table 15B were determined using the following procedures. Compound dilution serie...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/17/2023
Entry Details
US Patent

TargetSynaptic vesicular amine transporter(Human)
Neurocrine Biosciences

US Patent
LigandPNGBDBM611905(US11718618, Compound 4-56 | (2R,3R,11bR)-3-(2,2- d...)
Affinity DataKi:  0.520nMAssay Description:The human VMAT2 Ki values for the compounds listed in Table 15A and Table 15B were determined using the following procedures. Compound dilution serie...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/17/2023
Entry Details
US Patent

TargetSynaptic vesicular amine transporter(Human)
Neurocrine Biosciences

US Patent
LigandPNGBDBM611877(US11718618, Compound 4-32 | (2R,3R,11bR)-9-cyclobu...)
Affinity DataKi:  0.590nMAssay Description:The human VMAT2 Ki values for the compounds listed in Table 15A and Table 15B were determined using the following procedures. Compound dilution serie...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/17/2023
Entry Details
US Patent

TargetSynaptic vesicular amine transporter(Human)
Neurocrine Biosciences

US Patent
LigandPNGBDBM611937(US11718618, Compound 4-88 | (2R,3R,11bR)-9- (cyclo...)
Affinity DataKi:  0.680nMAssay Description:The human VMAT2 Ki values for the compounds listed in Table 15A and Table 15B were determined using the following procedures. Compound dilution serie...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/17/2023
Entry Details
US Patent

TargetSynaptic vesicular amine transporter(Human)
Neurocrine Biosciences

US Patent
LigandPNGBDBM611954(US11718618, Compound 4-121 | (2R,3R,11bR)-9-[(2,2-...)
Affinity DataKi:  0.820nMAssay Description:The human VMAT2 Ki values for the compounds listed in Table 15A and Table 15B were determined using the following procedures. Compound dilution serie...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/17/2023
Entry Details
US Patent

TargetSynaptic vesicular amine transporter(Human)
Neurocrine Biosciences

US Patent
LigandPNGBDBM611906(US11718618, Compound 4-57 | (2R,3R,11bR)-9-{[1- (d...)
Affinity DataKi:  0.930nMAssay Description:The human VMAT2 Ki values for the compounds listed in Table 15A and Table 15B were determined using the following procedures. Compound dilution serie...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/17/2023
Entry Details
US Patent

TargetSynaptic vesicular amine transporter(Human)
Neurocrine Biosciences

US Patent
LigandPNGBDBM611872(US11718618, Compound 4-27 | (2R,3R,11bR)-9-cyclopr...)
Affinity DataKi:  1nMAssay Description:The human VMAT2 Ki values for the compounds listed in Table 15A and Table 15B were determined using the following procedures. Compound dilution serie...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/17/2023
Entry Details
US Patent

TargetSynaptic vesicular amine transporter(Human)
Neurocrine Biosciences

US Patent
LigandPNGBDBM611858((2R,3R,11bR)-3-(2,2- dimethylpropyl)-9-ethoxy-10- ...)
Affinity DataKi:  1.10nMAssay Description:The human VMAT2 Ki values for the compounds listed in Table 15A and Table 15B were determined using the following procedures. Compound dilution serie...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/17/2023
Entry Details
US Patent

TargetSynaptic vesicular amine transporter(Human)
Neurocrine Biosciences

US Patent
LigandPNGBDBM611856(US11718618, Compound 4-15 | (2R,3R,11bR)-3-(2,2- d...)
Affinity DataKi:  1.10nMAssay Description:The human VMAT2 Ki values for the compounds listed in Table 15A and Table 15B were determined using the following procedures. Compound dilution serie...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/17/2023
Entry Details
US Patent

TargetSynaptic vesicular amine transporter(Human)
Neurocrine Biosciences

US Patent
LigandPNGBDBM611900(US11718618, Compound 4-55 | (2R,3R,11bR)-3-(2,2- d...)
Affinity DataKi:  1.10nMAssay Description:The human VMAT2 Ki values for the compounds listed in Table 15A and Table 15B were determined using the following procedures. Compound dilution serie...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/17/2023
Entry Details
US Patent

TargetSynaptic vesicular amine transporter(Human)
Neurocrine Biosciences

US Patent
LigandPNGBDBM611895(US11718618, Compound 4-50 | (2R,3R,11bR)-3-(2,2- d...)
Affinity DataKi:  1.40nMAssay Description:The human VMAT2 Ki values for the compounds listed in Table 15A and Table 15B were determined using the following procedures. Compound dilution serie...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/17/2023
Entry Details
US Patent

TargetSynaptic vesicular amine transporter(Human)
Neurocrine Biosciences

US Patent
LigandPNGBDBM611858((2R,3R,11bR)-3-(2,2- dimethylpropyl)-9-ethoxy-10- ...)
Affinity DataKi:  1.40nMAssay Description:The human VMAT2 Ki values for the compounds listed in Table 15A and Table 15B were determined using the following procedures. Compound dilution serie...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/17/2023
Entry Details
US Patent

TargetSynaptic vesicular amine transporter(Human)
Neurocrine Biosciences

US Patent
LigandPNGBDBM611953(US11718618, Compound 4-120 | (2R,3R,11bR)-3-(2,2- ...)
Affinity DataKi:  1.5nMAssay Description:The human VMAT2 Ki values for the compounds listed in Table 15A and Table 15B were determined using the following procedures. Compound dilution serie...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/17/2023
Entry Details
US Patent

TargetSynaptic vesicular amine transporter(Human)
Neurocrine Biosciences

US Patent
LigandPNGBDBM611908(US11718618, Compound 4-59 | 5-({[(2R,3R,11bR)-3-(2...)
Affinity DataKi:  1.5nMAssay Description:The human VMAT2 Ki values for the compounds listed in Table 15A and Table 15B were determined using the following procedures. Compound dilution serie...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/17/2023
Entry Details
US Patent

TargetSynaptic vesicular amine transporter(Human)
Neurocrine Biosciences

US Patent
LigandPNGBDBM611876(US11718618, Compound 4-31 | (2R,3R,11bR)-3-(2,2- d...)
Affinity DataKi:  1.60nMAssay Description:The human VMAT2 Ki values for the compounds listed in Table 15A and Table 15B were determined using the following procedures. Compound dilution serie...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/17/2023
Entry Details
US Patent

TargetSynaptic vesicular amine transporter(Human)
Neurocrine Biosciences

US Patent
LigandPNGBDBM611950(US11718618, Compound 4-117 | (2R,3R,11bR)-3-(2,2- ...)
Affinity DataKi:  2.20nMAssay Description:The human VMAT2 Ki values for the compounds listed in Table 15A and Table 15B were determined using the following procedures. Compound dilution serie...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/17/2023
Entry Details
US Patent

TargetSynaptic vesicular amine transporter(Human)
Neurocrine Biosciences

US Patent
LigandPNGBDBM611854(US11718618, Compound 4-13 | (2R,3R,11bR)-9-(2,2- d...)
Affinity DataKi:  2.20nMAssay Description:The human VMAT2 Ki values for the compounds listed in Table 15A and Table 15B were determined using the following procedures. Compound dilution serie...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/17/2023
Entry Details
US Patent

TargetSynaptic vesicular amine transporter(Human)
Neurocrine Biosciences

US Patent
LigandPNGBDBM611889(US11718618, Compound 4-44 | 2-(2-{[(2R,3R,11bR)-3-...)
Affinity DataKi:  2.40nMAssay Description:The human VMAT2 Ki values for the compounds listed in Table 15A and Table 15B were determined using the following procedures. Compound dilution serie...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/17/2023
Entry Details
US Patent

TargetSynaptic vesicular amine transporter(Human)
Neurocrine Biosciences

US Patent
LigandPNGBDBM611842(US11718618, Compound 4-1 | (2R,3R,11bR)-3-(2,2- di...)
Affinity DataKi:  2.40nMAssay Description:The human VMAT2 Ki values for the compounds listed in Table 15A and Table 15B were determined using the following procedures. Compound dilution serie...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/17/2023
Entry Details
US Patent

TargetSynaptic vesicular amine transporter(Human)
Neurocrine Biosciences

US Patent
LigandPNGBDBM611897((2R,3R,11bR)-3-(2,2- dimethylpropyl)-9-(methoxy- d...)
Affinity DataKi:  2.5nMAssay Description:The human VMAT2 Ki values for the compounds listed in Table 15A and Table 15B were determined using the following procedures. Compound dilution serie...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/17/2023
Entry Details
US Patent

TargetSynaptic vesicular amine transporter(Human)
Neurocrine Biosciences

US Patent
LigandPNGBDBM611855(US11718618, Compound 4-14 | (2R,3R,11bR)-9-(2,2- d...)
Affinity DataKi:  2.60nMAssay Description:The human VMAT2 Ki values for the compounds listed in Table 15A and Table 15B were determined using the following procedures. Compound dilution serie...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/17/2023
Entry Details
US Patent

TargetSynaptic vesicular amine transporter(Human)
Neurocrine Biosciences

US Patent
LigandPNGBDBM611909(US11718618, Compound 4-60 | (2R,3R,11bR)-9-(benzyl...)
Affinity DataKi:  3.10nMAssay Description:The human VMAT2 Ki values for the compounds listed in Table 15A and Table 15B were determined using the following procedures. Compound dilution serie...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/17/2023
Entry Details
US Patent

TargetSynaptic vesicular amine transporter(Human)
Neurocrine Biosciences

US Patent
LigandPNGBDBM611853(US11718618, Compound 4-12 | (2S,3R,11bR)-3-(2,2- d...)
Affinity DataKi:  3.40nMAssay Description:The human VMAT2 Ki values for the compounds listed in Table 15A and Table 15B were determined using the following procedures. Compound dilution serie...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/17/2023
Entry Details
US Patent

TargetSynaptic vesicular amine transporter(Human)
Neurocrine Biosciences

US Patent
LigandPNGBDBM611910(US11718618, Compound 4-61 | (2R,3R,11bR)-3-(2,2- d...)
Affinity DataKi:  3.5nMAssay Description:The human VMAT2 Ki values for the compounds listed in Table 15A and Table 15B were determined using the following procedures. Compound dilution serie...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/17/2023
Entry Details
US Patent

TargetSynaptic vesicular amine transporter(Human)
Neurocrine Biosciences

US Patent
LigandPNGBDBM611911(US11718618, Compound 4-62 | (2R,3R,11bR)-3-(2,2- d...)
Affinity DataKi:  3.70nMAssay Description:The human VMAT2 Ki values for the compounds listed in Table 15A and Table 15B were determined using the following procedures. Compound dilution serie...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/17/2023
Entry Details
US Patent

TargetSynaptic vesicular amine transporter(Human)
Neurocrine Biosciences

US Patent
LigandPNGBDBM611883(US11718618, Compound 4-38 | (2R,3R,11bR)-3-(2,2- d...)
Affinity DataKi:  3.70nMAssay Description:The human VMAT2 Ki values for the compounds listed in Table 15A and Table 15B were determined using the following procedures. Compound dilution serie...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/17/2023
Entry Details
US Patent

TargetSynaptic vesicular amine transporter(Human)
Neurocrine Biosciences

US Patent
LigandPNGBDBM611912(US11718618, Compound 4-63 | (2R,3R,11bR)-3-(2,2- d...)
Affinity DataKi:  4.20nMAssay Description:The human VMAT2 Ki values for the compounds listed in Table 15A and Table 15B were determined using the following procedures. Compound dilution serie...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/17/2023
Entry Details
US Patent

TargetSynaptic vesicular amine transporter(Human)
Neurocrine Biosciences

US Patent
LigandPNGBDBM611900(US11718618, Compound 4-55 | (2R,3R,11bR)-3-(2,2- d...)
Affinity DataKi:  4.80nMAssay Description:The human VMAT2 Ki values for the compounds listed in Table 15A and Table 15B were determined using the following procedures. Compound dilution serie...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/17/2023
Entry Details
US Patent

TargetSynaptic vesicular amine transporter(Human)
Neurocrine Biosciences

US Patent
LigandPNGBDBM611888(US11718618, Compound 4-43 | 2-(2-{[(2R,3R,11bR)-3-...)
Affinity DataKi:  4.80nMAssay Description:The human VMAT2 Ki values for the compounds listed in Table 15A and Table 15B were determined using the following procedures. Compound dilution serie...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/17/2023
Entry Details
US Patent

TargetSynaptic vesicular amine transporter(Human)
Neurocrine Biosciences

US Patent
LigandPNGBDBM611913(US11718618, Compound 4-64 | (2R,3R,11bR)-3-(2,2- d...)
Affinity DataKi:  5.5nMAssay Description:The human VMAT2 Ki values for the compounds listed in Table 15A and Table 15B were determined using the following procedures. Compound dilution serie...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/17/2023
Entry Details
US Patent

TargetSynaptic vesicular amine transporter(Human)
Neurocrine Biosciences

US Patent
LigandPNGBDBM611860(US11718618, Compound 4-18 | (2R,3R,11bR)-3-(2,2- d...)
Affinity DataKi:  5.5nMAssay Description:The human VMAT2 Ki values for the compounds listed in Table 15A and Table 15B were determined using the following procedures. Compound dilution serie...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/17/2023
Entry Details
US Patent

TargetSynaptic vesicular amine transporter(Human)
Neurocrine Biosciences

US Patent
LigandPNGBDBM611869(US11718618, Compound 4-25 | (2R,3R,11bR)-3-(2,2- d...)
Affinity DataKi:  5.5nMAssay Description:The human VMAT2 Ki values for the compounds listed in Table 15A and Table 15B were determined using the following procedures. Compound dilution serie...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/17/2023
Entry Details
US Patent

TargetSynaptic vesicular amine transporter(Human)
Neurocrine Biosciences

US Patent
LigandPNGBDBM611948(US11718618, Compound 4-115 | (2R,3R,11bR)-3-(2,2- ...)
Affinity DataKi:  6.10nMAssay Description:The human VMAT2 Ki values for the compounds listed in Table 15A and Table 15B were determined using the following procedures. Compound dilution serie...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/17/2023
Entry Details
US Patent

TargetSynaptic vesicular amine transporter(Human)
Neurocrine Biosciences

US Patent
LigandPNGBDBM611897((2R,3R,11bR)-3-(2,2- dimethylpropyl)-9-(methoxy- d...)
Affinity DataKi:  6.60nMAssay Description:The human VMAT2 Ki values for the compounds listed in Table 15A and Table 15B were determined using the following procedures. Compound dilution serie...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/17/2023
Entry Details
US Patent

TargetSynaptic vesicular amine transporter(Human)
Neurocrine Biosciences

US Patent
LigandPNGBDBM611890(US11718618, Compound 4-45 | 1-(2-{[(2R,3R,11bR)-3-...)
Affinity DataKi:  7.30nMAssay Description:The human VMAT2 Ki values for the compounds listed in Table 15A and Table 15B were determined using the following procedures. Compound dilution serie...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/17/2023
Entry Details
US Patent

TargetSynaptic vesicular amine transporter(Human)
Neurocrine Biosciences

US Patent
LigandPNGBDBM611861(US11718618, Compound 4-19 | (2R,3R,11bR)-3-(2,2- d...)
Affinity DataKi:  8.10nMAssay Description:The human VMAT2 Ki values for the compounds listed in Table 15A and Table 15B were determined using the following procedures. Compound dilution serie...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/17/2023
Entry Details
US Patent

TargetSynaptic vesicular amine transporter(Human)
Neurocrine Biosciences

US Patent
LigandPNGBDBM611914(US11718618, Compound 4-65 | (2R,3R,11bR)-9-(2-chlo...)
Affinity DataKi:  8.70nMAssay Description:The human VMAT2 Ki values for the compounds listed in Table 15A and Table 15B were determined using the following procedures. Compound dilution serie...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/17/2023
Entry Details
US Patent

TargetSynaptic vesicular amine transporter(Human)
Neurocrine Biosciences

US Patent
LigandPNGBDBM611896(US11718618, Compound 4-51 | (2R,3R,11bR)-9-(3,3-di...)
Affinity DataKi:  9.40nMAssay Description:The human VMAT2 Ki values for the compounds listed in Table 15A and Table 15B were determined using the following procedures. Compound dilution serie...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/17/2023
Entry Details
US Patent

TargetSynaptic vesicular amine transporter(Human)
Neurocrine Biosciences

US Patent
LigandPNGBDBM611915(US11718618, Compound 4-66 | (2R,3R,11bR)-3-(2,2- d...)
Affinity DataKi:  10nMAssay Description:The human VMAT2 Ki values for the compounds listed in Table 15A and Table 15B were determined using the following procedures. Compound dilution serie...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/17/2023
Entry Details
US Patent

TargetSynaptic vesicular amine transporter(Human)
Neurocrine Biosciences

US Patent
LigandPNGBDBM611898(US11718618, Compound 4-53 | (2R,3R1bR)-3-(2,2- dim...)
Affinity DataKi:  12nMAssay Description:The human VMAT2 Ki values for the compounds listed in Table 15A and Table 15B were determined using the following procedures. Compound dilution serie...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/17/2023
Entry Details
US Patent

TargetSynaptic vesicular amine transporter(Human)
Neurocrine Biosciences

US Patent
LigandPNGBDBM611884(US11718618, Compound 4-39 | (2R,3R,11bR)-3-(2,2- d...)
Affinity DataKi:  12nMAssay Description:The human VMAT2 Ki values for the compounds listed in Table 15A and Table 15B were determined using the following procedures. Compound dilution serie...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/17/2023
Entry Details
US Patent

TargetSynaptic vesicular amine transporter(Human)
Neurocrine Biosciences

US Patent
LigandPNGBDBM611899(US11718618, Compound 4-54 | (2R,3R,11bR)-3-(2,2- d...)
Affinity DataKi:  12nMAssay Description:The human VMAT2 Ki values for the compounds listed in Table 15A and Table 15B were determined using the following procedures. Compound dilution serie...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/17/2023
Entry Details
US Patent

TargetSynaptic vesicular amine transporter(Human)
Neurocrine Biosciences

US Patent
LigandPNGBDBM611875(US11718618, Compound 4-30 | (2R,3R,11bR)-3-(2,2- d...)
Affinity DataKi:  12nMAssay Description:The human VMAT2 Ki values for the compounds listed in Table 15A and Table 15B were determined using the following procedures. Compound dilution serie...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/17/2023
Entry Details
US Patent

TargetSynaptic vesicular amine transporter(Human)
Neurocrine Biosciences

US Patent
LigandPNGBDBM611951(US11718618, Compound 4-118 | (2S,3R,11bR)-3-(2,2- ...)
Affinity DataKi:  13nMAssay Description:The human VMAT2 Ki values for the compounds listed in Table 15A and Table 15B were determined using the following procedures. Compound dilution serie...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/17/2023
Entry Details
US Patent

TargetSynaptic vesicular amine transporter(Human)
Neurocrine Biosciences

US Patent
LigandPNGBDBM611916(US11718618, Compound 4-67 | (2R,3R,11bR)-3-(2,2- d...)
Affinity DataKi:  14nMAssay Description:The human VMAT2 Ki values for the compounds listed in Table 15A and Table 15B were determined using the following procedures. Compound dilution serie...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/17/2023
Entry Details
US Patent

TargetSynaptic vesicular amine transporter(Human)
Neurocrine Biosciences

US Patent
LigandPNGBDBM611866(US11718618, Compound 4-22 | (2R,3R,11bR)-3-(2,2- d...)
Affinity DataKi:  14nMAssay Description:The human VMAT2 Ki values for the compounds listed in Table 15A and Table 15B were determined using the following procedures. Compound dilution serie...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/17/2023
Entry Details
US Patent

TargetSynaptic vesicular amine transporter(Human)
Neurocrine Biosciences

US Patent
LigandPNGBDBM611852(US11718618, Compound 4-11 | (2S,3R,11bR)-9-(2,2- d...)
Affinity DataKi:  14nMAssay Description:The human VMAT2 Ki values for the compounds listed in Table 15A and Table 15B were determined using the following procedures. Compound dilution serie...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/17/2023
Entry Details
US Patent

Displayed 1 to 50 (of 109 total ) | Next | Last >>
Jump to: